Following new guidelines from the National Institute for Care and Excellence (NICE) which recommends that adults with Type 1 diabetes should be offered a choice of glucose sensor, children should be offered real-time Continuous Glucose Monitoring (rt-CGM) and people with Type 2 diabetes using insulin can be considered for rt-CGM as an alternative to their current sensor, DexCom, Inc. and NHS England have announced the availability of the Dexcom ONE rt-CGM System on prescription via the NHS drug tariff to everyone with Type 1 or Type 2 diabetes using insulin. This is the first time that a rt-CGM is made available to people with diabetes at the pharmacy level in the UK.
As of 1 August, patients will receive their starter pack – including information on the product and usage, a sensor and transmitter – from the hospital or GP surgery once prescribed, after which they can go to the pharmacy for their repeat prescription.
As a next step, Dexcom will be working closely with healthcare professionals to ensure the diabetes community can benefit as quickly as possible from reimbursement and wider availability of Dexcom CGM.
To read more, CLICK HERE.